Effects of Different Continuous Aerobic Training Protocols in a Heterozygous Mouse Model of Niemann-Pick Type C Disease.

Niemann-Pick type C disease aerobic training mouse model muscle plasticity neurodegeneration synaptic plasticity

Journal

Journal of functional morphology and kinesiology
ISSN: 2411-5142
Titre abrégé: J Funct Morphol Kinesiol
Pays: Switzerland
ID NLM: 101712257

Informations de publication

Date de publication:
18 Jul 2020
Historique:
received: 30 06 2020
revised: 10 07 2020
accepted: 15 07 2020
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 21 1 2021
Statut: epublish

Résumé

The positive effects of physical activity on cognitive functions are widely known. Aerobic training is known to promote the expression of neurotrophins, thus inducing an increase in the development and survival of neurons, as well as enhancing synaptic plasticity. Based on this evidence, in the present study, we analyze the effects of two different types of aerobic training, progressive continuous (PC) and varying continuous (VC), on synaptic and muscular plasticity in heterozygous mice carrying the genetic mutation for Niemann-Pick type C disease. We also analyze the effects on synaptic plasticity by extracellular recordings in vitro in mouse hippocampal slices, while the morphological structure of muscle tissue was studied by transmission electron microscopy. Our results show a modulation of synaptic plasticity that varies according to the type of training protocol used, and only the VC protocol administered twice a week, has a significantly positive effect on long-term potentiation. On the contrary, ultrastructural analysis of muscle tissue shows an improvement in cellular conditions in all trained mice. These results confirm the beneficial effects of exercise on quality of life, supporting the hypothesis that physical activity could represent an alternative therapeutic strategy for patients with Niemann-Pick type C disease.

Identifiants

pubmed: 33467268
pii: jfmk5030053
doi: 10.3390/jfmk5030053
pmc: PMC7739240
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Consolidate the Foundations Project 2015 University of Rome Tor Vergata
ID : 2015

Références

Cell Mol Life Sci. 2016 Mar;73(5):975-83
pubmed: 26646070
Neurosci Lett. 1992 Nov 9;146(2):176-8
pubmed: 1337194
Trends Neurosci. 2007 Sep;30(9):464-72
pubmed: 17765329
Science. 1999 Sep 17;285(5435):1870-4
pubmed: 10489359
Neurology. 2012 Apr 24;78(17):1323-9
pubmed: 22517108
Science. 1997 Jul 11;277(5323):232-5
pubmed: 9211850
J Neurochem. 2000 Aug;75(2):634-43
pubmed: 10899938
Biomed Rep. 2020 May;12(5):267-275
pubmed: 32257190
Acta Neuropathol. 1995;90(6):547-51
pubmed: 8615074
Hippocampus. 2010 Dec;20(12):1327-31
pubmed: 20043285
J Neurol Sci. 2013 Dec 15;335(1-2):219-20
pubmed: 24035292
Neuroscience. 2012 Jan 27;202:309-17
pubmed: 22155655
Acta Neuropathol. 1995;89(3):227-38
pubmed: 7754743
Trends Cogn Sci. 2013 Oct;17(10):525-44
pubmed: 24029446
Brain. 1995 Feb;118 ( Pt 1):119-29
pubmed: 7894998
Annu Rev Psychol. 2015 Jan 3;66:769-97
pubmed: 25251492
J Biol Chem. 2001 Mar 30;276(13):10314-9
pubmed: 11152466
J Neurosci. 2002 Aug 1;22(15):6515-25
pubmed: 12151531
Eur J Histochem. 2014 Sep 12;58(3):2403
pubmed: 25308844
Ann Ist Super Sanita. 2019 Oct-Dec;55(4):330-337
pubmed: 31850859
Behav Brain Res. 2017 Aug 14;332:59-63
pubmed: 28559180
Altern Lab Anim. 2002 Dec;30 Suppl 2:217-9
pubmed: 12513679
J Transl Med. 2017 Feb 15;15(1):34
pubmed: 28202082
J Neurol. 2014 Sep;261(9):1651-61
pubmed: 24263406
Neural Plast. 2016;2016:3830424
pubmed: 26885401
Int Rev Neurobiol. 2019;147:45-74
pubmed: 31607362
Orphanet J Rare Dis. 2013 Oct 17;8:166
pubmed: 24135395
Eur J Neurosci. 2011 Apr;33(7):1264-74
pubmed: 21375602

Auteurs

Ida Cariati (I)

Medical-Surgical Biotechnologies and Translational Medicine, Department of Clinical Sciences and Translational Medicine, "Tor Vergata" University of Rome, Via Montpellier 1, 00133 Rome, Italy.

Manuel Scimeca (M)

Department of Biomedicine and Prevention, "Tor Vergata" University of Rome, Via Montpellier 1, 00133 Rome, Italy.

Virginia Tancredi (V)

Department of System Medicine, "Tor Vergata" University of Rome, Via Montpellier 1, 00133 Rome, Italy.
Centre of Space Bio-medicine, "Tor Vergata" University of Rome, Via Montpellier 1, 00133 Rome, Italy.

Agata Grazia D'Amico (AG)

Department of Drug Science, University of Catania, 95125 Catania, Italy.

Gabriele Pallone (G)

Department of System Medicine, "Tor Vergata" University of Rome, Via Montpellier 1, 00133 Rome, Italy.

Mattia Palmieri (M)

Department of System Medicine, "Tor Vergata" University of Rome, Via Montpellier 1, 00133 Rome, Italy.

Claudio Frank (C)

National Center for Rare Diseases, Istituto Superiore di Sanità, viale Regina Elena 299, 00161 Rome, Italy.

Giovanna D'Arcangelo (G)

Department of System Medicine, "Tor Vergata" University of Rome, Via Montpellier 1, 00133 Rome, Italy.
Centre of Space Bio-medicine, "Tor Vergata" University of Rome, Via Montpellier 1, 00133 Rome, Italy.

Classifications MeSH